Consensus-Derived Quality Performance Indicators for NET Care

An article titled “Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care” has recently been published in Journal of Clinical Medicine (JCM) as part of the Special Issue Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms.

Click here for website link to article 

Click here to download pdf of the full article

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

NECA Joins Boehringer Ingelheim Panel Discussion on Clinical Trials and Patient Access

Expressions of interest open for ANZSNM nurse and allied health workshop in Canberra

NECA partners with Oncidium ahead of World Radiotheranostics Day 2026

Bringing Together Experts to Improve NET Patient Care: NECA at the 5th NET Preceptorship

Tax Appeal

Screenshot 2026-05-20 at 2.12.07 PM

Help 31,000+ neuroendocrine cancer patients get the specialised care they deserve.

Every dollar raised is fully tax deductible and helps fund much needed advocacy efforts and patient support.